Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1979-01-04
1981-09-22
Hunt, Brooks H.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
128659, 424 15, 424 9, A61K 4900, A61K 4300, G01T 100
Patent
active
042910129
ABSTRACT:
A process is disclosed for the preparation of a diagnositc agent for scanning the RES, in particular the liver, by mixing the sodium salt of 1-phenyl-2,3-dimethyl-pyrazolone-4-methylamino-methylsulfonic acid or 1-phenyl-2,3-dimethyl-pyrazolone in aqueous solution with tin(II) salt, adjusting the solution to a pH between 4 and 9, optionally lyophilizing the mixture and adding .sup.99m Tc-pertechnetate in physiological saline solution.
REFERENCES:
patent: 3743713 (1973-07-01), Kato et al.
patent: 4066742 (1978-01-01), Garrett
patent: 4087516 (1978-05-01), Laidler et al.
Kloss Gerhard
Molter Michael
Schickel Eberhard
Strecker Helmut
Hoechst Aktiengesellschaft
Hunt Brooks H.
Nucker Christine M.
LandOfFree
Technetium-labelled diagnostic agent for the examination of the does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Technetium-labelled diagnostic agent for the examination of the , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Technetium-labelled diagnostic agent for the examination of the will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-335093